Suci Tech Secures Over RMB 100 Million Series A Funding to Advance Magnetic Levitation Technology in Biopharma and Semiconductor Industries

Recently,Suzhou Supermag Intelligent Technology Co., Ltd. (hereinafter referred to as “Supermag”) Announces Completion of Cumulative Series A Financing Exceeding RMB 100 Million, led by Qiming Venture Partners and SMIC Juyuan, with Runzhang Venture Capital as co-lead investor, and jointly funded by CDB Innovation Investment, Oriza Holdings, and Oriza Yuan Dian. The financing proceeds will be primarily used for the mass production of magnetic levitation rotary tables, magnetic levitation liquid pumps, and magnetic levitation stirring systems, to expand applications in high-end markets across various fields, and to continue developing other independently innovated products.

Supermag, established in 2017, possesses internationally leading bearingless magnetic levitation motor technology and products. The company is committed to providing high-cleanliness, low-shear magnetic levitation motors, fluid transport, and mixing solutions for the biopharmaceutical, semiconductor, and chemical industries. In the highly barriered field of magnetic levitation, the company has successively broken through overseas technological monopolies,Successfully developed the world’s first magnetic levitation molten salt pump and China’s first magnetic levitation wafer turntable, with fully self-developed magnetic levitation pumps and stirring systems.. Meanwhile, the company can provide customized services to customers based on its underlying magnetic levitation control technology. Currently,Supermag has established partnerships with numerous clients valued at over RMB 10 billion, achieving particularly high market penetration among leading enterprises in the biopharmaceutical magnetic levitation equipment sector.。

Supermag’s core team possesses extensive technical expertise and experience in the field of magnetic levitation, complemented by rich backgrounds in overseas work and industrialization. Dr. Yin Chengke, founder of Supermag, has over 20 years of experience in R&D of magnetic levitation technology. He developed China’s first magnetically levitated artificial heart, among other innovations, and has led or participated in numerous scientific research projects, promoting the application of magnetic levitation technology in aerospace, energy, medical devices, and other fields.

Maglev trains have brought magnetic levitation technology into the public eye on a large scale for the first time. By utilizing magnetic forces to counteract gravity and levitate objects, this technology eliminates physical contact and friction, offering advantages such as cleanliness, energy efficiency, and safety. It is applied in fields including aerospace, transportation, and healthcare, with virtually all equipment requiring drive systems capable of leveraging magnetic levitation technology. In this high-capacity, rapidly growing sector,Supermag focuses on high-end sectors such as biopharmaceuticals, developing “small yet precise” products.。

With the high-quality development of the biopharmaceutical industry, biopharmaceutical technologies are continuously being refined, and biopharmaceutical processes must meet stringent standards such as high cleanliness and low shear stress. The manufacturing processes for biologics are highly complex. Traditional biopharmaceutical equipment can generate particulate matter due to friction during operation, leading to contamination. Additionally, excessive shear stress may cause cell damage, thereby reducing the yield of biopharmaceutical products.

Magnetic levitation technology can minimize particle generation to the greatest extent. In the field of biopharmaceuticals,Supermag offers disposable and reusable maglev pumps, mixers, and flow sensors to help biopharmaceutical companies process shear-sensitive fluids, such as cell-based vaccines, biologics, and gene therapies. Additionally, it can customize its maglev product designs to meet downstream biopharmaceutical needs.。

Supermag’s magnetic levitation pumps and stirrers have broken the long-standing technological monopoly held by foreign companies and achieved enhanced performance.Magnetic levitation pumps offer advantages such as intelligent control, compact size, and reduced leakage risk, while magnetic levitation stirring systems provide benefits including low shear stress and stable, reliable performance.。

The high technological sophistication of magnetic levitation technology stems from its integration of electromagnetics, sensing and control, materials science, fluid dynamics, system structural design, and integrated commissioning, resulting in exceptionally high comprehensive technical barriers. Supermag’s control technology originated from the Chinese Academy of Sciences. Its team has accumulated years of interdisciplinary knowledge and experience in mathematics, physics, electromagnetics, and fluid dynamics, and has independently developed all control algorithms and software. Building on this foundation, Supermag can develop customized products according to customer needs, driving innovation in magnetic levitation equipment and enhancing end-application performance. Leveraging its foundational technological expertise, Supermag’s product pipeline enjoys sustainable development advantages.

Supermag has established its own R&D and production base spanning nearly 4,000 square meters, equipped with Class 10,000 cleanrooms and Class 100 workstations., fully meeting the ultra-clean requirements of fields such as biopharmaceuticals, and demonstrating strong manufacturing capabilities. According to Supermag, the most challenging aspect of magnetic levitation technology lies in achieving stable suspension and rotation of the rotor, which primarily relies on software and algorithms. Most raw materials used in magnetic levitation products are identical to those in non-magnetic levitation products, and there are no particular difficulties in processing and manufacturing. Moreover, these products feature a more compact design and reduced material consumption, offering practical advantages over traditional mechanical bearing products in large-scale mass production.

From a market-oriented perspective, Supermag currently focuses its business on the domestic market, with 80% of its customers based in China. However, leveraging its scarce magnetic levitation products globally and a comprehensive international patent portfolio, Supermag possesses distinct advantages for global expansion and is actively developing overseas markets. In the future, Supermag may establish overseas subsidiaries to achieve synchronized development of its domestic and international operations, thereby promoting the effective application of magnetic levitation technology worldwide.

Regarding this round of financing,Chen Nan, Executive Director of Qiming Venture Partnersstated: “The Supermag team has accumulated years of theoretical and practical expertise in magnetic levitation technology, successfully commercializing the technology across multiple application domains on numerous occasions. Over the past two years, the company’s product planning and commercialization achievements in the semiconductor and biopharmaceutical sectors have been highly distinctive and pioneering. We have full confidence that Supermag is the only platform-oriented technology and product company in China capable of democratizing ‘elite’ magnetic levitation technology for widespread adoption.”

Wang Xinran, Partner at SMIC Capital“Magnetic levitation technology is a novel bearing technology. Its non-contact motion characteristics deliver significant advantages, including wear-free operation, ultra-clean performance, high energy efficiency, and precise control, inevitably sparking a new technological revolution in the industrial sector. Supermag boasts profound expertise in magnetic levitation technology. Its independently developed magnetic levitation products have been integrated into the supply chains of multiple clients with valuations exceeding RMB 10 billion, with certain performance metrics surpassing those of foreign competitors. We believe that Supermag will evolve into a platform company specializing in magnetic levitation technology, continuously providing high-quality products and services required for ultra-clean processes to customers in critical industries such as semiconductors and biopharmaceuticals.”

Du Min, Partner at Oriza Holdings“Supermag has been deeply engaged in the field of magnetic levitation for over a decade, possessing fully independent core technologies and intellectual property rights. The team has previously demonstrated strong technical capabilities in areas such as artificial hearts and satellite attitude control. Currently, the company has achieved mass production of key components including magnetic levitation wafer stages, magnetic levitation pumps, and magnetic levitation stirring systems. As critical precision control components in the industrial sector, these products have gained recognition and procurement from benchmark downstream customers. We are confident that the team will continue to achieve greater commercial success and research breakthroughs in the field of magnetic levitation, thereby contributing to the development of China’s advanced manufacturing industry.”

Runzhang Venture Capital TeamIt stated: “The technological barriers for magnetic levitation are relatively high, making it a scarce resource in China currently, while downstream market demand is urgent. As a platform company centered on magnetic levitation control technology, Supermag possesses the capability for continuous, independent product iteration. The company has successfully achieved mass production of several critical products that were previously bottlenecks, and these have been validated and recognized by multiple leading industry clients. Its performance in overseas markets has also been impressive, with promising prospects for future development.”

Qiming Venture Partners, established in 2006, has successively set up offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. Currently, Qiming Venture Partners manages 11 U.S. dollar funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early-stage and growth-stage companies in the Technology and Consumer (T&C) and Healthcare sectors. To date, Qiming Venture Partners has invested in more than 530 high-growth innovative enterprises, among which over 200 have either gone public on major exchanges such as the New York Stock Exchange, NASDAQ, Hong Kong Stock Exchange, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through mergers and acquisitions. Additionally, more than 70 portfolio companies have become industry-recognized unicorns or super unicorns.

SMIC Capital Equity Investment Management (Shanghai) Co., Ltd. (“SMIC Capital”) specializes in equity investments in the integrated circuit (IC) industry, committed to long-term value investing by identifying and creating value. Co-founded by SMIC and a team of seasoned investment professionals, SMIC Capital manages assets exceeding RMB 30 billion. Its investment portfolio spans the entire IC industry chain, covering all stages of equity investment, including angel, venture capital (VC), private equity (PE), public company investments, and mergers and acquisitions (M&A). To date, it has invested in over 300 companies, some of which have already been listed on capital markets.

Runzhang Venture Capital was established on October 21, 2020. Adhering to national policies on emerging industries and aligning with the demands of Suzhou’s local advantageous industries and future key planned sectors, it focuses on strategic emerging industries such as healthcare, new energy, new materials, hard technology, TMT, mass consumption, and artificial intelligence.

China Development Bank Technology Venture Capital Co., Ltd. (abbreviated as “CDB Tech VC”) was established in November 2016. It is the first national-level science and technology innovation investment institution in the banking industry and serves as the venture capital investment platform of China Development Bank. With a registered capital of RMB 5 billion, the company primarily engages in equity investments in sci-tech enterprises at the seed, start-up, and growth stages. In coordination with China Development Bank’s investment-loan linkage model, it provides complementary loans to portfolio companies, thereby supporting technological innovation and the development of specialized, refined, distinctive, and innovative small and medium-sized enterprises (SRDI SMEs), and contributing to national self-reliance and strength in science and technology as well as strengthening and supplementing industrial chains.

Oriza Holdings is a state-owned investment holding company with assets under management exceeding RMB 100 billion. Its business spans three core segments: equity investment, debt financing, and investment and financing services. Committed to empowering the growth of technology-driven enterprises, Oriza Holdings strives to become the preferred capital services brand for entrepreneurs.